Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by JDavenporton Jun 14, 2022 3:48pm
173 Views
Post# 34756100

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Quote...

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Quote...
I apologize to the readers here for responding to cmonreally24, beenthere and Finallytherock. I have put them, as well as MBT123, Glasshalffull1, and fuzzyjr back on ignore.
 
These guys are very combative, as I am. But somebody has to bite the bullet so I'm ending my responses to them except if they post a rational comment about Bioasis that deserves a response.
 
I also suggest that others refrain from responding to them. It's your call but these guys don't care about Bioasis and its shareholders. They don't deserve the recognition of their existence that responses bring. They just want to inflict as much pain on people as they can and this forum happens to be one of their chosen vehicles for doing that.
 
I won't be posting original articles on here much anymore. Instead, I'll reactivate StoxComm for this and other purposes. I was going to post on this forum a piece related to the very exciting Enhertu news from Daiichi Sankyo last week. The Enhertu science just got very interesting with aspects that ought to be discussed relative to Bioasis and xB3. In short, I now have even greater doubt that Enhertu should be delivered to the brain with xB3. I'll explain soon but it's definitely nerd stuff.

It just hit me that if I don't respond to trolls and stop posting original articles then I won't have must to post about on here. Yeah, well...
 
jd
<< Previous
Bullboard Posts
Next >>